Pharma

Wockhardt jumps on US FDA nod for generic drug By eHealth Network - 19 November 2009

• Share:
• 
• 
• 

 

Wockhardt and Sun Pharmaceutical have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug.

Following which, share price of Wockhardt jumped to a high of Rs 185, and is now up 1.5% at Rs 183. The counter has seen trades of around 36,600 shares so far on the BSE.

Meanwhile, Sun Pharma is trading flat at Rs 1,440. Around 5,880 shares have changed hands at the counter on the BSE.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Tags: hypertension nicardipine Sun Pharma Sun Pharmaceutical United States Food and Drug Administration USFDA Wockhardt

Related Pharma

---

Pharma

First release of Rs. 166 Crores in Pharmaceutical PLI Incentives

The Indian government is concentrating on producing high-end medical devices and pharmaceuticals as part of its effort t...

By eHealth Network 22-02-2023

Pharma

Government to launch incentive scheme to encourage pharmaceutical business R&D: DCGI Somani

The Drugs Controller General of India, Dr. V. G. Somani said on Friday that the center is getting ready to launch a rese...

By eHealth Network 21-01-2023

Pharma

Pharmaceuticals and Chemical Outreach & Consultation Workshop held in Punjab, aims to bridge gap between Academia and Industry

Punjab Bureau of Investment Promotion (PBIP) has orgainsed a One-day Outreach & Consultation Workshop on bridging th...

By eHealth Network 22-09-2022

Pharma

Doceree Appoints Anil Dobhal as Global Chief Technology Officer

Doceree,a global platform building unprecedented solutions for HCP programmatic marketing with proprietary data tools, t...

By eHealth Network 28-04-2022

Pharma

India allows emergency use of two vaccines for U-12 children

Drugs Controller General of India (DCGI) authorized the emergency use of two Covid-19 vaccines for children under the ag...

By eHealth Network 27-04-2022

Pharma

HealthPlix releases “EMR on Mobile” bridging digital divide between Bharat and Doctors

HealthPlix Technologies, a SaaS platform for doctors, released the mobile version of its AI-powered EMR. Available on al...

By eHealth Network 12-04-2022

Pharma

CLIRNET launches Doctor’s Voice - digital platform for discovery of healthcare delivery challenges

CLIRNET, a Live Digital CME & Doctor Generated Medical Content Platform, has announced the launch of Doctor’s Voic...

By eHealth Network 07-04-2022

Pharma

Doceree Closes $11 Million Series A Funding Round Led by Eight Roads Ventures

Doceree, the first global network of physician-only platforms for programmatic messaging, today announced the completion...

By eHealth Network 07-04-2022

Pharma

UP’s Vaccine Feat: Over 2 cr in 15-18 age group vaccinated with first dose

Aiming at providing protection cover to children in the age group of 15-18, Uttar Pradesh has so far administered vaccin...

By eHealth Network 25-03-2022

Pharma

Covid Vaccination for 12-14 year age group and booster dose for 60+ to commence from March 16

Union Health Minister Mansukh Mandaviya has informed that the Covid-19 vaccination for 12-14-year-olds and 'precaution d...

By eHealth Network 14-03-2022